Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005477-99-002312
Filing Date
1999-05-13
Accepted
1999-05-13 00:00:00
Documents
3
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 117004
2 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11.1 1435
3 FINANCIAL DATA SCHDULE EX-27.1 2301
  Complete submission text file 0001005477-99-002312.txt   122420
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21589 | Film No.: 99620731
SIC: 2834 Pharmaceutical Preparations